Business Development

TerSera Therapeutics has the platform to achieve sustainable, high-growth rates to build a leading pharmaceutical company. Our team brings proven experience and thoughtful solutions to commercial therapies that improve patient outcomes.

With proven experience and a talented leadership team — coupled with the financial strength of a leading private equity firm, GTCR — we develop solutions that create value for patients and stakeholders alike.

Initial target opportunities include approved products currently in market, as well as products in late-stage development. Therapeutic areas of interest include, but are not limited to:

· Allergy/Immunology

· CNS Disorders

· Endocrinology

· Gastroenterology

· Infectious Diseases

· Oncology

· Orphan Diseases

· Rheumatology

· Transplant-Related Therapies

· Urology

· Women’s Health

Please contact us to discuss possible partnership opportunities.

About GTCR

Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Financial Services & Technology, Healthcare, Technology, Media & Telecommunications and Growth Business Services industries. The Chicago-based firm pioneered The Leaders Strategy™ - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $12 billion in over 200 companies. For more information, please visit www.gtcr.com.